Liver Stem Cells

Volume 826 of the series Methods in Molecular Biology pp 179-188


Intravenous Human Mesenchymal Stem Cells Transplantation in NOD/SCID Mice Preserve Liver Integrity of Irradiation Damage

  • Moubarak MouiseddineAffiliated withIRSN, DRPH/SRBE/LTCRA
  • , Sabine FrançoisAffiliated withIRSN, DRPH/SRBE/LTCRA
  • , Maâmar SouidiAffiliated withIRSN, DRPH/SRBE/LTCRA
  • , Alain ChapelAffiliated withIRSN, DRPH/SRBE/LTCRA Email author 

* Final gross prices may vary according to local VAT.

Get Access


This work was initiated in an effort to evaluate the potential therapeutic contribution of the infusion of mesenchymal stem cells (MSC) for the correction of liver injuries. We subjected NOD–SCID mice to a 10.5-Gy abdominal irradiation and we tested the biological and histological markers of liver injury in the absence and after infusion of expanded human MSC. Irradiation alone induced a significant elevation of the ALT and AST. Apoptosis in the endothelial layer of vessels was observed. When MSC were infused in mice, a significant decrease of transaminases was measured, and a total disappearance of apoptotic cells. MSC were not found in liver. To explain the protection of liver without MSC engraftment, we hypothesize an indirect action of MSC on the liver via the intestinal tract. Pelvic or total body irradiation induces intestinal absorption defects leading to an alteration of the enterohepatic recirculation of bile acids. This alteration induces an increase in Deoxy Cholic Acid (DCA) which is hepatoxic. In this study, we confirm these results. DCA concentration increased approximately twofold after irradiation but stayed to the baseline level after MSC injection. We propose from our observations that, following irradiation, MSC infusion indirectly corrected liver dysfunction by preventing gut damage. This explanation would be consistent with the absence of MSC engraftment in liver. These results evidenced that MSC treatment of a target organ may have an effect on distant tissues. This observation comes in support to the interest for the use of MSC for cellular therapy in multiple pathologies proposed in the recent years.

Key words

Human Mesenchymal stem cells Liver Irradiation exposure NOD/SCID mice PCR AST ALT Liver bilic acids Therapeutic transplantation